DUBLIN--(BUSINESS WIRE)--The "Erectile Dysfunction - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
Erectile Dysfunction - Pipeline Insight, 2019 offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Erectile Dysfunction development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline Products covered across the following Developmental Stages:
- Clinical
- Non-clinical
- Inactive: Discontinued and/or Dormant
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
The report assesses the active Erectile Dysfunction pipeline products by developmental stage, product type, molecule type, and administration route.
Reasons to Buy
- Establish comprehensive understanding of the pipeline activity across this Erectile Dysfunction to formulate effective R&D strategies
- Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
- Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Erectile Dysfunction therapeutics
- Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress
Topics Covered
1. Report Introduction
2. Erectile Dysfunction Overview
3. Pipeline Therapeutics
- An Overview of Pipeline Products for Erectile Dysfunction
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
- Product Description
- Research and Development
- Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
- Product Description
- Research and Development
- Product Development Activities
7. Therapeutic Assessment
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
- Product Description
- Research and Development
-
Product Development Activities
Companies Featured
- Apricus Biosciences Inc.
- Astellas Pharma Inc.
- Biolab Farmaceutica Ltda.
- Biopharm GmbH
- Can-Fite BioPharma Ltd.
- Fabre-Kramer Pharmaceuticals Inc.
- Futura Medical PLC
- Hanmi Pharmaceuticals Co. Ltd.
- Humanetics Corp.
- IntelGenx Corp.
- Ion Channel Innovations LLC
- iX Biopharma Ltd.
- Mezzion Pharma Co. Ltd.
- Mitsubishi Tanabe Pharma Corp.
- Monosol Rx LLC
- NAL Pharmaceuticals Ltd.
- Palatin Technologies Inc.
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/bfm4l6/erectile?w=4
